Form D — Ollin Biosciences, Inc.
0002141184-26-000002 · filed Jun 24, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $330,000,000
- Reported amount sold
- $156,249,990
- Minimum investment
- $0
- Investors
- 32
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Ollin Biosciences, Inc.
- CIK
- 2141184
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 1250 S. CAPITAL OF TEXAS HWY
AUSTIN, TX 78746 - Phone
- 512-885-4957
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jason Ehrlich · Executive OfficerAUSTIN, TX Find on LinkedIn ↗
-
Paul Berns · DirectorAUSTIN, TX Find on LinkedIn ↗
-
Jason Coloma · DirectorAUSTIN, TX Find on LinkedIn ↗
-
Cariad Chester · DirectorAUSTIN, TX Find on LinkedIn ↗
-
Fred Cohen · DirectorAUSTIN, TX Find on LinkedIn ↗
-
Alaa Halawa · DirectorAUSTIN, TX Find on LinkedIn ↗
-
Travis Murdoch · DirectorAUSTIN, TX Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗